• Slider Image

Cancer Genomics & Proteomics

CGP_NEW_BANNER

ONLINE ISSN: 1790-6245new_highwire_logo

 

Cancer Genomics & Proteomics (CGP) is an international online-only open access, peer reviewed bimonthly journal devoted to the rapid publication of original high quality articles and reviews on the applications of genomic and proteomic technology to experimental and clinical cancer research. CGP was established in 2004.

Special Issue

Cancer Invasion and Metastasis Mechanisms – 2025

1. TOPICS: A. Mechanisms of Cancer Invasion

1. Epithelial-to-Mesenchymal transition (EMT)
2. Tumor microenvironment and invasion
3. Extracellular matrix degradation

B. Mechanisms of Metastasis

1. Circulating tumor cells and metastasis
2. Pre-metastatic niche formation
3. Organotropism in metastasis
4. Resistance to antimetastatic agents

2. Deadline for article(s) submission: May 30, 2025.
3. The instructions to Authors of CANCER GENOMICS & PROTEOMICS apply to this special issue, in the same way they apply to any CANCER GENOMICS & PROTEOMICS issue.
4. Review articles should preferably not exceed 12 printed pages, corresponding to roughly 48 typewritten pages or roughly 12,000 words. There will be no page charges. Color figures should be charged US $350 per page.
5. Upon acceptance, Authors will be asked to pay an online publication fee of USD 1,100 for articles up to 8 online pages (including figures and tables). Each additional excess page will be charged USD 60.00. Color will not be charged.
7. The special issue is scheduled for publication in September 2025.
8. Manuscripts should be submitted for publication through our new online submission system: www.iiar-submissions.com

Special Issue

Transcriptomics: Identification of Fusion Transcripts; Non-coding RNAs; Discovery of New Transcripts – 2025

1. TOPICS: A. Identification of Fusion Transcripts

1. Detection and characterization of fusion genes
2. Role of fusion transcripts in cancer

B. Non-coding RNAs

1. Role of microRNAs and lncRNAs in gene regulation
2. Non-coding RNAs as biomarkers

C. Discovery of New Transcripts

1. Advances in transcriptomic profiling
2. Functional characterization of novel transcripts

2. Deadline for article(s) submission: September 30, 2025.
3. The instructions to Authors of CANCER GENOMICS & PROTEOMICS apply to this special issue, in the same way they apply to any CANCER GENOMICS & PROTEOMICS issue.
4. Review articles should preferably not exceed 12 printed pages, corresponding to roughly 48 typewritten pages or roughly 12,000 words. There will be no page charges. Color figures should be charged US $350 per page.
5. Upon acceptance, Authors will be asked to pay an online publication fee of USD 1,100 for articles up to 8 online pages (including figures and tables). Each additional excess page will be charged USD 60.00. Color will not be charged.
7. The special issue is scheduled for publication in January 2026.
8. Manuscripts should be submitted for publication through our new online submission system: www.iiar-submissions.com

Our special issue of CANCER GENOMICS AND PROTEOMICS on ‘Emerging Technologies in Cancer Research” is now online!

Click here to see the contents

Cancer Genomics & Proteomics is published online-only with open-access through HighWire Press.

Contents of Current Issue
  • 2004 – 2023
  • 20 volumes
  • over 8,500 pages
  • over 630 open access original articles
  • 108 open access reviews
  • over 3,800 authors
  • conference abstracts
  • included in all abstracting services
  • online open access with HighWire Press
  • safe processing of all submitted manuscripts
  • rapid publication within 1-2 months of acceptance
  • no fees for language and style corrections
  • immediate contact with the Editorial Office

ANTICANCER RESEARCH USA, Inc.
111 Bay Avenue, Highlands, NJ 07732, USA.
e-mail: journals@iiar-anticancer.org

Information – Editorial & Production Office:
Managing Editor: G. J. Delinasios, International Institute of Anticancer Research,
1st km Kapandritiou- Kalamou Rd., P.O.Box 22, Kapandriti, Attiki 19014, Greece.
Tel & Fax : +30-22950-52945, +30-22950-53389
e-mail:journals@iiar-anticancer.org

Please submit your article only through our online submission system